Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Aug
16
2022
Recent Federal Developments - August 2022 Bergeson & Campbell, P.C.
Jul
17
2019
EFSA Publishes Scientific Opinion on Proposed Amendment to EU Specifications for Titanium Dioxide (E 171) Bergeson & Campbell, P.C.
Jul
26
2019
U.K. Announces Open Consultation Call For Evidence To Develop Standards For Compostable, And Biobased Plastics Bergeson & Campbell, P.C.
Aug
5
2019
EPA Improves Transparency for New Chemicals Review Program under TSCA Bergeson & Campbell, P.C.
Aug
30
2019
NY Department of Environmental Conservation Household Cleansing Product Information Disclosure Program Ruled “Null and Void” Bergeson & Campbell, P.C.
Dec
28
2022
EPA Finds Carbon Tetrachloride, as a Whole Chemical Substance, Poses an Unreasonable Risk to Human Health Bergeson & Campbell, P.C.
Jan
4
2023
Petition Filed to Add Polyphenylene Sulfide to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Jan
18
2023
Congress Enacts Modernization of Cosmetics Regulation Act of 2022, Significantly Strengthening Regulation of Cosmetics Bergeson & Campbell, P.C.
Mar
21
2023
EUON Posts Nanopinions on Graphene Electronic Tattoos and How to Monitor the Crystal Defect Structure in Nanomaterials Bergeson & Campbell, P.C.
Apr
22
2023
France Extends Due Date for R-Nano Declarations to May 31, 2023 Bergeson & Campbell, P.C.
Jan
22
2020
ECHA Publishes Q&A from Webinar on Revised REACH Annexes for Nanomaterials Bergeson & Campbell, P.C.
Jun
1
2023
BETO Announces Novel State-of-the-Art Workflow Technology to Accelerate Biomanufacturing Research Bergeson & Campbell, P.C.
Mar
17
2016
Biotechnology: Case Studies of Hypothetical, Genetically Engineered Organisms Bergeson & Campbell, P.C.
Jun
8
2023
EUON Posts Nanopinions on Using SWCNTs to Measure Biochemical Processes and on Experiments Involving Zebrafish to Elicit an Immune Response Bergeson & Campbell, P.C.
Apr
7
2016
NAS Releases Agenda for First Future Biotechnology Products and Regulatory System Committee Meeting Bergeson & Campbell, P.C.
Mar
5
2020
NIOSH CIB on Practices in Occupational Risk Assessment Addresses Nanomaterials Bergeson & Campbell, P.C.
Mar
9
2020
EPA Expediting Emerging Viral Pathogens Claim Submissions Bergeson & Campbell, P.C.
May
5
2016
EPA Issues Pesticide Tolerance Crop Grouping Program Amendment IV Bergeson & Campbell, P.C.
Mar
17
2020
Recent Federal Developments - FDA - March 2020 Bergeson & Campbell, P.C.
Jul
21
2023
EPA Extends Comment Period on Proposed SNURs for 18 Chemicals Made from Plastic Waste-Based Feedstocks Bergeson & Campbell, P.C.
Jul
31
2023
APHIS 2022 Impact Report Includes Summary of Biotechnology Activities Bergeson & Campbell, P.C.
Aug
2
2023
EC Committee Updates Guidance on the Safety Assessment of Nanomaterials in Cosmetics Bergeson & Campbell, P.C.
Sep
14
2023
NNCO Will Host Symposium on “Enabling the Nanotechnology Revolution” on October 10, 2023 Bergeson & Campbell, P.C.
Aug
12
2016
US Environmentalist And Organic Crop Farm Groups Want Overhaul Of Federal Biotechnology Strategy Bergeson & Campbell, P.C.
Sep
9
2016
Florida House Members Request Emergency Authorization to Combat Aedes aegypti Mosquitoes with Oxitec Technology Bergeson & Campbell, P.C.
Jun
8
2020
Senate Finance Committee Holds Hearing on FDA’s Foreign Drug Manufacturing Inspection Process Bergeson & Campbell, P.C.
Nov
22
2023
Global Regulatory Update for November 2023 Bergeson & Campbell, P.C.
Jan
28
2017
Top International News in Chemical Policy and Regulation - January 27, 2017: Europe Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins